SAR240550
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SAR240550, covering 2013-09-24 to 2017-03-22. Get the full timeline:
Most recent: Clinical Trial Update: Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer Patients [Phase 2]